StemTek Therapeutics
Bilbao
About StemTek Therapeutics
StemTek is a biopharmaceutical company focused on the research and development of drugs for cancer treatment. It utilizes stem cell centric point-of-view technologies for cancer therapy. It allows users to profile their pipeline of compounds for their effect on cancer stem cell populations, using 3D culture models. The company was founded in Angel Martin and Olatz Esnaola and is based in Bilbao, Spain.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $54.3K
- Funding stage: Seed
- Last round: Seed (Jan 2016)
- Website: stemtektherapeutics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Oncology, Therapeutics, Wellness
Social Profiles
Canonical: https://fsome.com/organization/stemtek-therapeutics-1194589 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.